Adsorption of CO₂ on ZSM-5 Zeolite: Analytical Investigation via a Multilayer Statistical Physics Model

In this paper, a synthesized zeolite (ZSM-5) is used as an adsorbent to analyze the adsorption phenomenon of carbon dioxide. This investigation, based on the statistical physics treatment, applied the multilayer model with saturation to understand the CO2 adsorption on four samples, namely M-ZSM-5 (M = Na+, Mg2+, Zn2+, La3+), at various temperatures T = 0 °C, 30 °C and 60 °C. The modeling results indicated that CO2 adsorption occurred via a non-parallel orientation on the ZSM-5 surface. The CO2 adsorption capacities varied from 26.14 to 28.65 cm3/g for Na-ZSM-5, from 25.82 to 27.97 cm3/g for Mg-ZSM-5, from 54.82 to 68.63 cm3/g for La-ZSM-5 and from 56.53 to 74.72 cm3/g for Zn-ZSM-5. Thus, Zn-ZSM-5 exhibits the highest adsorption amount. The analysis of the adsorption energies shows that the adsorption of CO2 on ZSM-5 zeolite is a physisorption phenomenon that could be controlled thanks to the energy parameters obtained via the numerical findings using the multilayer statistical model. Finally, the distribution of site energy was determined to confirm the physical character of the interactions between adsorbate/adsorbent and the heterogeneity of the zeolite surface

Mycobacterium caprae

Mycobacterium caprae, a member of the Mycobacterium tuberculosis complex, causes tuberculosis (TB) in man and animals. Some features distinguish M. caprae from its epidemiological twin, Mycobacterium bovis: M. caprae is evolutionarily older, accounts for a smaller burden of zoonotic TB and is not globally distributed, but primarily restricted to European countries. M. caprae occurs only in a low proportion of human TB cases and this proportion may even decrease, if progress toward eradication of animal TB in Europe continues. So why bother, if M. caprae is not an enigma for diagnostic TB tests and if resistance against first-line drugs is a rarity with M. caprae? This 'European' pathogen of zoonotic TB asks interesting questions regarding the definition of a species. The latter, seemingly only an academic question, particularly requires and challenges the collaboration between human and veterinary medicine